Amgen invests over $600 million in new science and innovation center at US headquarters, creating hundreds of jobs.

Amgen plans to invest over $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center will bring together researchers and scientists to accelerate the discovery of next-generation therapeutics and create hundreds of U.S. jobs. This investment reflects Amgen's long-standing commitment to U.S. innovation and state-of-the-art operations, with over $40 billion invested in manufacturing and R&D since the Tax Cuts and Jobs Act of 2017.